{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:14:05Z","timestamp":1790612045032,"version":"4.1.0"},"reference-count":34,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,3,30]]},"DOI":"10.1536\/ihj.23-589","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T22:18:08Z","timestamp":1711750688000},"page":"218-229","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Value of Troponin Levels to Cardiac Function and Prognosis in Patients with Fulminant Myocarditis"],"prefix":"10.1536","volume":"65","author":[{"given":"Naoki","family":"Shibata","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine"},{"name":"Department of Advanced Medicine, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Izawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ohte","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aichi Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of CHANGE PUMP 2 investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","first-page":"e69","volume":"141","year":"2020","unstructured":"1. Kociol RD, Cooper LT, Fang JC, <i>et al<\/i>. Recognition and initial management of fulminant myocarditis: A scientific statement from the American Heart Association. Circulation 2020; 141: e69-92.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sharma AN, Stultz JR, Bellamkonda N, Amsterdam EA. Fulminant myocarditis: Epidemiology, pathogenesis, diagnosis, and management. Am J Cardiol 2019; 124: 1954-60.","DOI":"10.1016\/j.amjcard.2019.09.017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Aoyama N, Izumi T, Hiramori K, <i>et al<\/i>. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002; 66: 133-44.","DOI":"10.1253\/circj.66.133"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ammirati E, Cipriani M, Lilliu M, <i>et al<\/i>. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 2017; 136: 529-45.","DOI":"10.1161\/CIRCULATIONAHA.117.026386"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McCarthy RE 3rd, Boehmer JP, Hruban RH, <i>et al<\/i>. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-5.","DOI":"10.1056\/NEJM200003093421003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cooper LT Jr. Myocarditis. N Engl J Med 2009; 360: 1526-38.","DOI":"10.1056\/NEJMra0800028"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ammirati E, Veronese G, Bottiroli M, <i>et al<\/i>. Update on acute myocarditis. Trends Cardiovasc Med 2021; 31: 370-9.","DOI":"10.1016\/j.tcm.2020.05.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chong SZ, Fang CY, Fang HY, <i>et al<\/i>. Associations with the in-hospital survival following extracorporeal membrane oxygenation in adult acute fulminant myocarditis. J Clin Med 2018; 7: 452.","DOI":"10.3390\/jcm7110452"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Asaumi Y, Yasuda S, Morii I, <i>et al<\/i>. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 2005; 26: 2185-92.","DOI":"10.1093\/eurheartj\/ehi411"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Maejima Y, Yasu T, Kubo N, <i>et al<\/i>. Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device. Circulation journal : official journal of the Japanese Circulation Society 2004; 68: 829-33.","DOI":"10.1253\/circj.68.829"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kondo T, Morimoto R, Mutsuga M, <i>et al<\/i>. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock. Int J Artif Organs 2021; 44: 846-53.","DOI":"10.1177\/03913988211040530"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Combes A, Leprince P, Luyt CE, <i>et al<\/i>. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36: 1404-11.","DOI":"10.1097\/CCM.0b013e31816f7cf7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chen YS, Yu HY, Huang SC, <i>et al<\/i>. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transplant 2005; 24: 81-7.","DOI":"10.1016\/j.healun.2003.09.038"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lippi G. Biomarkers: Novel troponin immunoassay for early ACS rule-out. Nat Rev Cardiol 2016; 13: 9-10.","DOI":"10.1038\/nrcardio.2015.174"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Bachmaier K, Mair J, Offner F, Pummerer C, Neu N. Serum cardiac troponin T and creatine kinase-MB elevations in murine autoimmune myocarditis. Circulation 1995; 92: 1927-32.","DOI":"10.1161\/01.CIR.92.7.1927"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lauer B, Niederau C, K\u00fchl U, <i>et al<\/i>. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 1354-9.","DOI":"10.1016\/S0735-1097(97)00317-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Greaves K, Oxford JS, Price CP, Clarke GH, Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch Intern Med 2003; 163: 165-8.","DOI":"10.1001\/archinte.163.2.165"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997; 95: 163-8.","DOI":"10.1161\/01.CIR.95.1.163"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mirabel M, Luyt CE, Leprince P, <i>et al<\/i>. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 2011; 39: 1029-35.","DOI":"10.1097\/CCM.0b013e31820ead45"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lorusso R, Centofanti P, Gelsomino S, <i>et al<\/i>. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: A 5-year multi-institutional experience. Ann Thorac Surg 2016; 101: 919-26.","DOI":"10.1016\/j.athoracsur.2015.08.014"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wang D, Li S, Jiang J, <i>et al<\/i>. Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci 2019; 62: 187-202.","DOI":"10.1007\/s11427-018-9385-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Veronese G, Ammirati E, Chen C, <i>et al<\/i>. Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis. Int J Cardiol 2021; 324: 131-8.","DOI":"10.1016\/j.ijcard.2020.10.063"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Felker GM, Boehmer JP, Hruban RH, <i>et al<\/i>. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000; 36: 227-32.","DOI":"10.1016\/S0735-1097(00)00690-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kondo T, Okumura T, Shibata N, <i>et al<\/i>. Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study. J Am Heart Assoc 2022; 11: e023719.","DOI":"10.1161\/JAHA.121.023719"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J 2011; 75: 734-43.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Platts DG, Sedgwick JF, Burstow DJ, Mullany DV, Fraser JF. The role of echocardiography in the management of patients supported by extracorporeal membrane oxygenation. J Am Soc Echocardiogr 2012; 25: 131-41.","DOI":"10.1016\/j.echo.2011.11.009"},{"key":"27","unstructured":"27. Yuan Z, Shioji K, Kishimoto C. Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis. Exp Clin Cardiol 2003; 8: 13-6."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes. J Am Coll Cardiol 2017; 70: 2363-75.","DOI":"10.1016\/j.jacc.2017.09.023"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kakino T, Yokoyama H, Eshima K. Significance of troponin I level as a marker of disease activity in the management of acute necrotizing eosinophilic myocarditis with normal peripheral eosinophil count: a case report. Eur Heart J Case Rep 2018; 2: yty139.","DOI":"10.1093\/ehjcr\/yty139"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gilotra NA, Minkove N, Bennett MK, <i>et al<\/i>. Lack of relationship between serum cardiac troponin I level and giant cell myocarditis diagnosis and outcomes. J Card Fail 2016; 22: 583-5.","DOI":"10.1016\/j.cardfail.2015.12.022"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hsu KH, Chi NH, Yu HY, <i>et al<\/i>. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center&apos;s experience. Eur J Cardiothorac Surg 2011; 40: 682-8.","DOI":"10.1016\/j.ejcts.2010.12.050"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Mason JW, O&apos;Connell JB, Herskowitz A, <i>et al<\/i>. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-75.","DOI":"10.1056\/NEJM199508033330501"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ammirati E, Veronese G, Brambatti M, <i>et al<\/i>. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2019; 74: 299-311.","DOI":"10.1016\/j.jacc.2019.04.063"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nagai T, Inomata T, Kohno T, <i>et al<\/i>. JCS 2023 Guideline on the diagnosis and treatment of myocarditis. Circ J 2023; 87: 674-754.","DOI":"10.1253\/circj.CJ-22-0696"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/2\/65_23-589\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T04:45:50Z","timestamp":1711773950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/2\/65_23-589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-589","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"article-number":"23-589"}}